Clinical Trials Browser

Not yet recruiting × Docetaxel × Genitourinary × Clear all

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT07419295 2026-02-19

TroFuse-031

Phase 3 Not yet recruiting

590 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT07344779 2026-01-26

ROAD

Not yet recruiting

1,600 enrolled

Genitourinary

Prostatic Neoplasms

NCT07365995 2026-01-26

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Phase 3 Not yet recruiting

736 enrolled

Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT07316686 2026-01-05

Lutécio

Phase 1 Not yet recruiting

18 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT07268794 2025-12-08

CONVERT-HB1

Phase 2 Not yet recruiting

112 enrolled

Genitourinary

Adenocarcinoma, Prostatic Neoplasms

NCT06430411 2024-05-28

OLIGOMET

Not yet recruiting

500 enrolled

Genitourinary

Prostatic Neoplasms

NCT06374914 2024-04-19

Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients

Not yet recruiting

120 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT06227065 2024-01-26

POLO

Phase 2 Not yet recruiting

28 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Clinical Trials

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

TroFuse-031

ROAD

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Lutécio

CONVERT-HB1

OLIGOMET

Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients

POLO